• Follow the Money: Harbinger Health’s Cancer-Screening Platform Study, Clinical Developments, In Vivo Reprogramming Therapies, More

    Clinical Research News | Harbinger Health funds 10,000-participant clinical study of its novel blood-based cancer screening platform; Nucleus RadioPharma establishes new radiopharmaceuticals manufacturing facilities; HHS funds behavioral health services and HIV prevention for underserved populations; and more.

    Oct 25, 2023

  • Multi-Lab Preclinical Model Aims To Solve The Reproducibility Crisis

    Clinical Research News | A new preclinical system put to the test by a network of labs to adaptively study a handful of stroke treatments has succeeded in demonstrating that high-quality science is “feasible, practical, and less expensive than doing things the wrong way."

    Oct 24, 2023

  • The Opportunities of Big Data Analytics in Clinical Trials

    Clinical Research News | The importance of data has become apparent to everybody in recent years. We can now interrogate massive datasets to add value to clinical trials and utilize technology more efficiently to speed up time to market.

    Oct 20, 2023

  • Anju Software’s TA Scan Diversity Data Wins European New Product Award

    Clinical Research News | Clinical Research News named the 2023 Best of Show Award winner at SCOPE Europe yesterday, honoring Anju Software’s TA Scan product and its expanded diversity dataset.

    Oct 19, 2023

  • Proteomics Enables Vastly Improved Cardiovascular Disease Prediction

    Clinical Research News | The rise and fall of blood protein levels over time is an astonishingly good way to assess the risk of major atherosclerotic cardiovascular disease (ASCVD) events such as myocardial infarction (heart attack), as well as an ideal biomarker of the progression of disease and its regression in response to treatment.

    Oct 12, 2023

  • Concierge-Style Services Becoming a Staple In Clinical Trials

    Clinical Research News | A growing number of companies, many originally in the meetings and events management industry, have pivoted to providing concierge-style services to clinical trial participants, enabling study sponsors to recruit patients faster, retain more of them, and get their outcomes data sooner.

    Oct 11, 2023

  • Navigating the Complex Vendor Selection Process With Dennis Salotti

    Clinical Research News | For clinical research sponsors, selecting the right vendor to do business with is complicated and time-consuming as sponsors deal with a growing number of vendors in the space, data privacy and security concerns, and the need to meet regulatory requirements, often across many different avenues. How does one efficiently navigate such a complex process to ensure downstream success?

    Oct 10, 2023

  • DIA 2023 Topic: The Industry-Wide Definition for RBQM

    Clinical Research News | At an RBQM expert dinner hosted by CluePoints and the Tufts Center for the Study of Drug Development’s (CSDD), Ken Getz shared the results of a global industry-wide survey on RBQM adoption and attitudes. The survey was conducted by Ken and his team at the Tufts CSDD in collaboration with CluePoints and Price Waterhouse Cooper.

    Oct 6, 2023

  • NCI To Conduct Massive Study To Evaluate Multi-Cancer Detection Assays

    Clinical Research News | The importance of data has become apparent to everybody in recent years. We can now interrogate massive datasets to add value to clinical trials and utilize technology more efficiently to speed up time to market.

    Oct 3, 2023

  • Medidata Launches Diversity Program, HHS Extends Partnership to Develop Monoclonal Antibodies, Flatiron Renews FDA Collab

    Clinical Research News | Flatiron Health renewed its collaboration with the Oncology Center of Excellence (OCE) of the United States Food and Drug Administration (FDA) to jointly develop and implement specific research projects; Medidata launched a program to improve diversity, equity, and inclusion in clinical trials; The U.S. Department of Health and Human Services (HHS) announced new details of its agreement with Regeneron to extend its public-private partnership to develop life-saving monoclonal antibodies as part of Project NextGen enhancing our preparedness for COVID-19 strains and variants; and more.

    Sep 28, 2023

  • Follow the Money: NCI Awards Grant For Prostate Cancer Treatment Study, Recruiting Participants For Immunotherapy Drug Trials

    Clinical Research News | The Icahn School of Medicine at Mount Sinai nets a grant to identify the best prostate cancer treatment for people with HIV; EverImmune will conduct a phase I/II clinical trial for its drug candidate Oncobax AK in patients undergoing immunotherapy; NIH establishes the Multi-Omics for Health and Disease Consortium to advance the generation and analysis of “multi-omic” data for human health research; more.

    Sep 27, 2023

  • Proteomics-Based Assays To Enable Precision Medicine For Ovarian Cancer

    Clinical Research News | Over 900 genes have been implicated in the resistance of tumors to platinum-based chemotherapy that map to many different cellular pathways, thwarting efforts to identify a biomarker to predict refractoriness.

    Sep 26, 2023

  • Adopting New Patient-Centric Payment Solutions for Whole-Industry Benefits

    Clinical Research News | The clinical trial landscape has a long-acknowledged problem – a lack of participant diversity. Most clinical trial participants are from higher-income households, white and male.

    Sep 22, 2023

  • COVID Vaccine Developers May Want To Pivot To Symptom Prevention

    Clinical Research News | Vaccine developers may want to consider designing formulations intended to prevent symptoms rather than infection, which the COVID-19 pandemic has demonstrated can be hard to do with any long-lasting effect.

    Sep 19, 2023

  • City of Hope’s Harmonized, Findable, Accessible Precision Medicine Data Platform

    Clinical Research News | INNOVATIVE PRACTICES AWARDS—When City of Hope wanted to better use its primary and secondary clinical research data and harmonize files on more than 700,000 patients so they were findable and accessible, the hospital built a highly scalable, compliant cloud-based platform.

    Sep 14, 2023

  • Changes Afoot In The Regulatory Landscape For Companion Diagnostics

    Clinical Research News | The U.S. Food and Drug Administration (FDA) has been making moves signaling its intention to better align the regulatory framework for companion diagnostics (CDx) to what is happening in real-world clinical practice.

    Sep 13, 2023

  • Study Finds Breast Cancer Spreads During Sleep, Highlights Role Of Hormones

    Clinical Research News | The recent discovery that the metastatic spread of breast cancer accelerates during sleep sparked a lively conversation at last month’s Next Generation Dx Summit about new paths of exploration for thwarting a deadly pan-cancer process claiming 12 lives worldwide every minute.

    Sep 12, 2023

  • Automated Speech Analysis: A Promising New Avenue For Patient Monitoring In Alzheimer’s Trials

    Clinical Research News | As experimental drugs to treat Alzheimer’s disease increasingly target the disease’s very initial stages, monitoring the impact of novel treatments on cognition has become a complex undertaking for trial sponsors.

    Sep 8, 2023

  • The Clinical Realities Of Chronic Wounds With Dr. Caroline Fife

    Clinical Research News | When Dr. Caroline Fife stepped into her first clinical trial in 1997, she was met with a waiting room packed with patients. Despite the large number of potential participants, none of them were considered healthy enough for the clinical trial. That was when she realized something was very wrong.

    Sep 5, 2023

  • Phastar Appoints New CEO, New Global Research Centers, New Partnerships Announced, More

    Clinical Research News | Phastar appoints a new CEO amid organization changes and growth plans; Celltrion opens a Global R&D Center in South Korea for research capabilities and technologies spanning all areas of biopharmaceutics; Clario and AliveCor, Standigm and Nashville Biosciences, C2i Genomics and the Tel Aviv Sourasky Medical Center (Ichilov) announce partnerships; more.

    Aug 31, 2023